Many trials that measure the efficacy and safety of antidepressants for MDD exclude one third of real-world patients with the disorder, a new study shows.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/major-gap-many-randomized-controlled-trials-major-depressive-2025a1000rlh?src=rss
Author :
Publish date : 2025-10-14 06:25:00
Copyright for syndicated content belongs to the linked Source.
